Cited by 67Lipoproteins and Cardiovascular HealthInflammatory Biomarkers in Disease PrognosisAdipokines, Inflammation, and Metabolic Diseases

Inflammatory markers and long-term risk of ischemic heart disease in men

St-Pierre, Annie C., Cantin, Bernard, Bergeron, Jean, Pirro, Matteo, Dagenais, Gilles R., Després, Jean-Pierre, Lamarche, Benoît·2005·Atherosclerosis

Abstract

We tested the hypothesis that elevated plasma interleukin-6 (IL-6), C-reactive protein (CRP) and fibrinogen concentrations are independent risk factors and interact in increasing the long-term risk of ischemic heart disease (IHD) in men. A total of 1982 IHD-free men from the Quebec Cardiovascular Study were followed over a period of 13 years during which 210 first fatal IHD events and non-fatal myocardial infarctions were recorded. Increased CRP levels (4th versus 1st quartile) were not associated with an increased risk of IHD after adjustment for non-lipid risk factors (age, body mass index, systolic blood pressure, diabetes, smoking and medication use at baseline), lipid risk factors (LDL and HDL cholesterol and triglyceride levels) and for IL-6 and fibrinogen (RR=0.70, 95% CI=0.43-1.13). High plasma IL-6 levels (4th versus 1st quartile) were associated with a 70% greater risk of IHD independent of confounding risk factors and of the other 2 inflammatory markers (RR=1.71, 95% CI=1.07-2.75). The relationship between high fibrinogen levels (4th versus 1st quartile) and IHD risk was borderline significant in multivariate analyses (RR=1.53, 95% CI=0.97-2.43). An inflammation score based on plasma IL-6 and fibrinogen levels improved the IHD risk predictive value of a multivariate model of traditional risk factors (p=0.03). Including plasma CRP levels into the inflammatory score provided no additional predictive value. In conclusion, elevated plasma IL-6 concentrations are more strongly related to IHD risk than CRP and fibrinogen. An inflammation score based on high plasma IL-6 and fibrinogen levels used in combination with traditional risk factors may improve our ability to adequately identify high risk individuals.

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2005.02.009

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • C-reactive protein may serve as a useful prognostic tool and as a marker of long-term mortality in patients with acute MI.

    “C-reactive protein, a heavily studied serum marker of inflammation, may serve as a useful prognostic tool and as a marker of long-term mortality in patients with acute MI (329, 332).”

    From Cardiac remodeling in obesity (2008) · cites this paper as [329]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
St-Pierre, A. C., Cantin, B., Bergeron, J., Pirro, M., Dagenais, G. R., Després, J.-P., & Lamarche, B.
Affiliations
  • Université Laval (CA)
  • Centre hospitalier de l'Université Laval (CA)
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2005-10
Volume
182
Issue
2
Pages
315-321
ISSN
0021-9150 (ISSN-L)
OpenAlex
W69281787
Cited by
67
References
30
Citations by year
2026: 1 · 2021: 2 · 2017: 3 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
9.83
Type
journal article
Language
en
Open access
closed
Locations
  • Atherosclerosis (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Heart and Stroke Foundation of Canada
  • Canada Research Chairs
Topics
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
ischemic heart disease, interleukin-6, C-reactive protein, fibrinogen, inflammatory markers, inflammation score, myocardial infarction, cardiovascular risk prediction, men
MeSH terms
Adult, C-Reactive Protein, Cholesterol, Fibrinogen, Follow-Up Studies, Humans, Male, Middle Aged, Quebec, Risk Factors, Biomarkers, Interleukin-6, Myocardial Ischemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review